Cargando…

Production and immunogenicity of different prophylactic vaccines for hepatitis C virus (Review)

Hepatitis C virus (HCV) infection is a global health challenge, and prophylactic vaccines are the most effective way to eliminate the infection. To date, numerous forms of preventive vaccines have entered the clinical trial stage, including the virus-like particle (VLP) vaccine, recombinant subunit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Qianqian, He, Kun, Zhang, Xiuhua, Xu, Mingjie, Zhang, Xiuping, Li, Huanjie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214603/ https://www.ncbi.nlm.nih.gov/pubmed/35761816 http://dx.doi.org/10.3892/etm.2022.11401

Ejemplares similares

Immunogenicity and reactogenicity of inactivated SARS-CoV-2 vaccines in healthy adults
por: Wu, Yufei, et al.
Publicado: (2023)

Prophylactic and Therapeutic Vaccination against Hepatitis C Virus (HCV): Developments and Future Perspectives
por: Major, Marian E.
Publicado: (2009)

Seroprevalence of hepatitis C virus in Jinan, China, 2008–2020
por: Xu, Mingjie, et al.
Publicado: (2023)

Antigenic determinants of hepatitis E virus and vaccine-induced immunogenicity and efficacy
por: Zhao, Qinjian, et al.
Publicado: (2012)

Qualitative differences in cellular immunogenicity elicited by hepatitis C virus T-Cell vaccines employing prime-boost regimens
por: Tan, Wendy G., et al.
Publicado: (2017)

Prophylactic Hepatitis E Vaccines: Antigenic Analysis and Serological Evaluation
por: Li, Yike, et al.
Publicado: (2020)

Immunogenicity of HPV prophylactic vaccines: Serology assays and their use in HPV vaccine evaluation and development
por: Pinto, Ligia A., et al.
Publicado: (2018)

Immunogenicity of two different hepatitis B vaccine schedules
por: Agladioglu, S. Y., et al.
Publicado: (2011)

A Heterologous Prime/Boost Vaccination Strategy Enhances the Immunogenicity of Therapeutic Vaccines for Hepatitis C Virus
por: Fournillier, Anne, et al.
Publicado: (2013)

Urgency and necessity of Epstein-Barr virus prophylactic vaccines
por: Zhong, Ling, et al.
Publicado: (2022)

Immunogenicity of recombinant hepatitis B vaccine: comparison of two different vaccination schedules
por: Agladioglu, S., et al.
Publicado: (2010)

Opinion Polls and Antibody Response Dynamics of Vaccination with COVID-19 Booster Vaccines
por: Wu, Yufei, et al.
Publicado: (2022)

Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine
por: Law, John L. M., et al.
Publicado: (2018)

Enhancing the antigenicity and immunogenicity of monomeric forms of hepatitis C virus E2 for use as a preventive vaccine
por: Center, Rob J., et al.
Publicado: (2020)

Immunogenicity of adenovirus-vector vaccine targeting hepatitis B virus: non-clinical safety assessment in non-human primates
por: Zhang, Xuefeng, et al.
Publicado: (2018)

Lassa virus diversity and feasibility for universal prophylactic vaccine
por: Lukashevich, Igor S., et al.
Publicado: (2019)

Cost-effectiveness of Prophylactic Zika Virus Vaccine in the Americas
por: Shoukat, Affan, et al.
Publicado: (2019)

Correction to: Immunogenicity of adenovirus-vector vaccine targeting hepatitis B virus: non-clinical safety assessment in non-human primates
por: Zhang, Xuefeng, et al.
Publicado: (2018)

Construction and Immunogenicity Analysis of Hepatitis C Virus (HCV) Truncated Non-Structural Protein 3 (NS3) Plasmid Vaccine
por: Pouriayevali, Mohammad-Hassan, et al.
Publicado: (2016)

A Novel Adeno-Associated Virus–Based Genetic Vaccine Encoding the Hepatitis C Virus NS3/4 Protein Exhibits Immunogenic Properties in Mice Superior to Those of an NS3-Protein-Based Vaccine
por: Zhu, Fengqin, et al.
Publicado: (2015)

Prophylactic effect of tenofovir on viral reactivation in immunocompromised pregnant women living with hepatitis B virus
por: Zhang, Le, et al.
Publicado: (2022)

The long-term immunogenicity of recombinant hepatitis B virus (HBV) vaccine: contribution of universal HBV vaccination in Italy
por: Coppola, Nicola, et al.
Publicado: (2015)

Immunogenicity and functional characterization of Leishmania-derived hepatitis C virus envelope glycoprotein complex
por: Grzyb, Katarzyna, et al.
Publicado: (2016)

Comparative Immunogenicity in Rabbits of the Polypeptides Encoded by the 5′ Terminus of Hepatitis C Virus RNA
por: Sominskaya, Irina, et al.
Publicado: (2015)

Heterologous virus peptide immunogen production: recombinant vaccine production in L-cell, Chinese hamster ovary, C127 cell culture
Publicado: (1989)

Inclusion of cGAMP within virus‐like particle vaccines enhances their immunogenicity
por: Chauveau, Lise, et al.
Publicado: (2021)

Hepatitis Delta Virus Acts as an Immunogenic Adjuvant in Hepatitis B Virus-Infected Hepatocytes
por: Tham, Christine Y.L., et al.
Publicado: (2020)

Safety and immunogenicity of a SARS-CoV-2 inactivated vaccine in patients with chronic hepatitis B virus infection
por: Xiang, Tiandan, et al.
Publicado: (2021)

Hepatitis C Virus and Vaccine Development
por: Naderi, Malihe, et al.
Publicado: (2014)

Preclinical Development and Production of Virus-Like Particles As Vaccine Candidates for Hepatitis C
por: Masavuli, Makutiro Ghislain, et al.
Publicado: (2017)

Cholera Prophylactic Vaccination
por: Roy, Ashutosh
Publicado: (1919)

The Status and Prospects of Epstein–Barr Virus Prophylactic Vaccine Development
por: Sun, Cong, et al.
Publicado: (2021)

Immunogenicity of SARS inactivated vaccine in BALB/c mice
por: Xiong, Sheng, et al.
Publicado: (2004)

A Hepatitis C Virus DNA Vaccine Encoding a Secreted, Oligomerized Form of Envelope Proteins Is Highly Immunogenic and Elicits Neutralizing Antibodies in Vaccinated Mice
por: Masavuli, Makutiro Ghislain, et al.
Publicado: (2019)

Optimized Hepatitis C Virus (HCV) E2 Glycoproteins and their Immunogenicity in Combination with MVA-HCV
por: Marín, María Q., et al.
Publicado: (2020)

A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates
por: Callendret, Benoit, et al.
Publicado: (2018)

The Immunogenicity of a Single Dose of Hepatitis A Virus Vaccines (Havrix® and Epaxal®) in Korean Young Adults
por: Lim, Jiseun, et al.
Publicado: (2014)

Immunogenicity of gold nanoparticle-based truncated ORF2 vaccine in mice against Hepatitis E virus
por: Rani, Dibya, et al.
Publicado: (2021)

Reappraisal of the Immunogenicity and Safety of Three Hepatitis A Vaccines in Adolescents
por: Yoon, Seo Hee, et al.
Publicado: (2016)

Development of a downstream process for the production of an inactivated whole hepatitis C virus vaccine
por: Lothert, Keven, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5ie4bgd8egt8m4rjdvmvkdih7r